![On-X Life Technologies Reports CE Mark Approval to Sell Its Mechanical Aortic Heart Valve with an Expanded Labeling Claim: a Reduction in the Required Use of Blood Thinners | Business Wire On-X Life Technologies Reports CE Mark Approval to Sell Its Mechanical Aortic Heart Valve with an Expanded Labeling Claim: a Reduction in the Required Use of Blood Thinners | Business Wire](https://mms.businesswire.com/media/20140115005231/en/399203/5/On-X-640.jpg)
On-X Life Technologies Reports CE Mark Approval to Sell Its Mechanical Aortic Heart Valve with an Expanded Labeling Claim: a Reduction in the Required Use of Blood Thinners | Business Wire
![On-X prosthetic heart valve design and features. (1) Pure carbon, (2)... | Download Scientific Diagram On-X prosthetic heart valve design and features. (1) Pure carbon, (2)... | Download Scientific Diagram](https://www.researchgate.net/profile/Shvetank-Agarwal/publication/274643388/figure/fig3/AS:391896066215944@1470446711510/On-X-prosthetic-heart-valve-design-and-features-1-Pure-carbon-2-Optimal-longer.png)
On-X prosthetic heart valve design and features. (1) Pure carbon, (2)... | Download Scientific Diagram
![U.S. FDA Grants Expanded Labeling Claim to On-X Life Technologies, Reducing Blood-Thinning Requirements for Heart Valve Patients | Business Wire U.S. FDA Grants Expanded Labeling Claim to On-X Life Technologies, Reducing Blood-Thinning Requirements for Heart Valve Patients | Business Wire](https://mms.businesswire.com/media/20150402005154/en/460461/5/On-x_heart_valve_Infographic_highres.jpg)
U.S. FDA Grants Expanded Labeling Claim to On-X Life Technologies, Reducing Blood-Thinning Requirements for Heart Valve Patients | Business Wire
![Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve - Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve -](https://ars.els-cdn.com/content/image/1-s2.0-S0002870320301940-gr1.jpg)
Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve -
![The composite image of examples of mechanical mitral valves from the... | Download Scientific Diagram The composite image of examples of mechanical mitral valves from the... | Download Scientific Diagram](https://www.researchgate.net/profile/Arash-Kheradvar/publication/266623621/figure/fig2/AS:601586485194768@1520440803284/The-composite-image-of-examples-of-mechanical-mitral-valves-from-the-major-manufactures.png)
The composite image of examples of mechanical mitral valves from the... | Download Scientific Diagram
![The four types of mechanical aortic valves used. The St Jude (a) and... | Download Scientific Diagram The four types of mechanical aortic valves used. The St Jude (a) and... | Download Scientific Diagram](https://www.researchgate.net/profile/Petr-Symersky/publication/51128238/figure/fig6/AS:667076796624903@1536054910608/The-four-types-of-mechanical-aortic-valves-used-The-St-Jude-a-and-the-Medtronic-Hall.jpg)
The four types of mechanical aortic valves used. The St Jude (a) and... | Download Scientific Diagram
![Permanent pacemaker implantation after On-X surgical aortic valve replacement: SWEDEHEART observational study | BMJ Open Permanent pacemaker implantation after On-X surgical aortic valve replacement: SWEDEHEART observational study | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/11/11/e047962/F2.large.jpg)